» Articles » PMID: 35171451

Induction of Salivary Gland-Like Tissue by Induced Pluripotent Stem Cells In Vitro

Overview
Date 2022 Feb 16
PMID 35171451
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To investigate the in vitro induction of salivary gland-like tissue by ips cells in an interferon regulatory factor 6 (IRF6) overexpression and parotid conditioned medium environment.

Methods: Urine-derived ips cells were isolated, identified, transfected with IRF6 and cultured in parotid conditioned medium to induce ips cells into salivary gland differentiation, morphological changes of ips cells were observed, CCK-8 was used to determine the cell proliferation efficiency and transcriptome sequencing was used to detect the expression of genes related to parotid gland formation.

Results: Immunofluorescence staining showed that the isolated ips cells were positive for NANOG, SSEA4 and OCT4 and had embryonic-like stem cell characteristics; CCK-8 showed that there was no statistical difference in the proliferation efficiency between the IRF6 induced group and the simple induced group after induction of ips cells into salivary glands. The results of transcriptome sequencing showed that there were a total of 643 differentially expressed genes, including 365 up-regulated genes and 278 down-regulated genes in the IRF6 induced group compared to the blank control group, and the salivary gland related genes HAPLN1, CCL2, MSX2, ANXA1, CYP11A1, HES1 and LUM were all highly expressed in the IRF6 induced group.

Conclusion: IRF6 promotes salivary gland differentiation in urine-derived iPSCs, and its mechanism of promoting differentiation may be that IRF6 upregulates the expression of HAPLN1, CCL2, MSX2, ANXA1, CYP11A1, HES1 and LUM to promote epithelial differentiation.

Citing Articles

Efficacy of Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cell Replacement Therapy in a Vascular Dementia Animal Model.

Kim J, Kang H, Lee J, Kim J, Geum D, Park D Tissue Eng Regen Med. 2025; .

PMID: 39953271 DOI: 10.1007/s13770-025-00706-z.


Current developments and opportunities of pluripotent stem cells-based therapies for salivary gland hypofunction.

Song W, Liu H, Su Y, Zhao Q, Wang X, Cheng P Front Cell Dev Biol. 2024; 12:1346996.

PMID: 38313227 PMC: 10834761. DOI: 10.3389/fcell.2024.1346996.

References
1.
Rocchi C, Emmerson E . Mouth-Watering Results: Clinical Need, Current Approaches, and Future Directions for Salivary Gland Regeneration. Trends Mol Med. 2020; 26(7):649-669. DOI: 10.1016/j.molmed.2020.03.009. View

2.
Lysik D, Niemirowicz-Laskowska K, Bucki R, Tokajuk G, Mystkowska J . Artificial Saliva: Challenges and Future Perspectives for the Treatment of Xerostomia. Int J Mol Sci. 2019; 20(13). PMC: 6651665. DOI: 10.3390/ijms20133199. View

3.
Jaskoll T, Luo W, Snead M . Msx-2 expression and glucocorticoid-induced overexpression in embryonic mouse submandibular glands. J Craniofac Genet Dev Biol. 1998; 18(2):79-87. View

4.
Dissemond J, Haberer D, Franckson T, Hillen U . The Van der Woude syndrome: a case report and review of the literature. J Eur Acad Dermatol Venereol. 2004; 18(5):611-3. DOI: 10.1111/j.1468-3083.2004.00996.x. View

5.
Neopane P, Paudel D, Yoshida K, Adhikari B, Morikawa T, Onishi A . Immunohistochemical Localization of RNase 7 in Normal and Inflamed Oral Epithelia and Salivary Glands. Acta Histochem Cytochem. 2019; 52(2):35-43. PMC: 6643094. DOI: 10.1267/ahc.18027. View